{"id":17956,"date":"2026-02-03T09:42:14","date_gmt":"2026-02-03T09:42:14","guid":{"rendered":"https:\/\/www.quantumrun.com\/consulting\/?p=17956"},"modified":"2026-02-03T09:44:11","modified_gmt":"2026-02-03T09:44:11","slug":"who-owns-pfizer","status":"publish","type":"post","link":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/","title":{"rendered":"Who Owns Pfizer"},"content":{"rendered":"\n<!DOCTYPE html>\n<html lang=\"en\">\n<head>\n    <meta charset=\"UTF-8\">\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1.0\">\n    <meta name=\"description\" content=\"Discover who owns Pfizer in 2025. Learn about major shareholders like Vanguard and BlackRock, the board of directors, company history, and ownership structure.\">\n    <style>\n\n        a:hover {\n            text-decoration: underline;\n        }\n        .key-stats {\n            background-color: #f8f9fa;\n            padding: 20px 25px;\n            border-radius: 8px;\n            margin-bottom: 25px;\n            border-left: 4px solid #0066cc;\n        }\n        .key-stats p {\n            margin: 10px 0;\n            font-size: 15px;\n        }\n        .shareholder-table {\n            max-width: 100%;\n            margin: 25px 0;\n            overflow-x: auto;\n        }\n        .shareholder-table table {\n            width: 100%;\n            border-collapse: collapse;\n            font-size: 14px;\n        }\n        .shareholder-table th {\n            background-color: #f5f5f5;\n            padding: 12px 10px;\n            text-align: left;\n            border-bottom: 2px solid #ddd;\n            font-weight: 600;\n        }\n        .shareholder-table th:nth-child(2),\n        .shareholder-table th:nth-child(3) {\n            text-align: center;\n        }\n        .shareholder-table td {\n            padding: 12px 10px;\n            border-bottom: 1px solid #eee;\n        }\n        .shareholder-table td:nth-child(2),\n        .shareholder-table td:nth-child(3) {\n            text-align: center;\n        }\n        .shareholder-table tr:hover {\n            background-color: #fafafa;\n        }\n        .source-note {\n            font-size: 12px;\n            color: #666;\n            margin-top: 8px;\n        }\n        .faq-section h3 {\n            color: #1a1a1a;\n        }\n        .faq-section p {\n            margin-bottom: 25px;\n        }\n        sup a {\n            color: #0066cc;\n        }\n    <\/style>\n<\/head>\n<body>\n\n<h2>Key Stats<\/h2>\n<div class=\"key-stats\">\n    <p>Market Cap: ~$142 billion (August 2025)<\/p>\n    <p>Projected 2025 Revenue: $61\u201364 billion<\/p>\n    <p>Institutional Ownership: ~68% of shares<\/p>\n    <p>Employees Worldwide: ~81,000<\/p>\n<\/div>\n\n<p>Pfizer Inc. is not owned by any single individual or entity. As a publicly traded company listed on the New York Stock Exchange under the ticker symbol PFE, ownership is distributed among institutional investors, mutual funds, and retail shareholders. The largest stakeholders are asset management giants Vanguard Group, BlackRock, and State Street Corporation, collectively holding around 20% of outstanding shares.<\/p>\n\n<p>The company, headquartered in New York City, reported net income of $8.03 billion in 2024. Pfizer&#8217;s portfolio spans oncology, vaccines, immunology, and rare diseases. The <a href=\"https:\/\/www.quantumrun.com\/prediction\/healthcare-nearing-revolution-future-health-p1\" rel=\"nofollow\">future of healthcare<\/a> continues to evolve, and Pfizer remains positioned as one of the largest pharmaceutical firms globally by revenue and market cap.<\/p>\n\n<h2>Who Owns Pfizer?<\/h2>\n\n<p>Pfizer operates as an independent publicly traded corporation with no controlling shareholder. Ownership is spread across thousands of investors worldwide.<\/p>\n\n<h3>Institutional vs. Retail Ownership<\/h3>\n\n<p>Approximately 68% of Pfizer shares are held by institutional investors. These include pension funds, mutual funds, index funds, and asset management firms. Retail investors\u2014individual shareholders\u2014account for about 35% of ownership. Insider ownership from company executives and board members remains below 0.3%.<\/p>\n\n<h3>No Single Controlling Entity<\/h3>\n\n<p>Unlike private companies with concentrated ownership, Pfizer&#8217;s shareholder base is highly diversified. The &#8220;Big Three&#8221; asset managers\u2014Vanguard, BlackRock, and State Street\u2014hold the largest positions, but none exceeds 10% ownership individually. This structure means no single investor dictates company decisions, though large institutional holders wield influence through proxy voting on matters like board elections and executive compensation.<\/p>\n\n<h2>History of Pfizer Co-founders<\/h2>\n\n<p>The company traces its origins to 1849 when two German immigrant cousins launched a small chemical business in Brooklyn, New York.<\/p>\n\n<h3>Charles Pfizer and Charles Erhart<\/h3>\n\n<p>Charles Pfizer, a chemist, partnered with his cousin Charles F. Erhart, a confectioner, to establish &#8220;Charles Pfizer &#038; Company.&#8221; Their first successful product was santonin, an antiparasitic treatment made palatable through candy flavoring\u2014leveraging Erhart&#8217;s confectionery expertise.<\/p>\n\n<h3>Early Expansion and Innovation<\/h3>\n\n<p>The company grew steadily through the late 1800s, opening its first facility outside New York in Chicago in 1882. By 1906, annual sales exceeded $3 million. During the 1930s and 1940s, Pfizer pioneered fermentation techniques for vitamin C production and later became the world&#8217;s largest producer of penicillin during World War II. This manufacturing expertise earned the company an Army-Navy &#8220;E&#8221; Award in 1943 and established Pfizer&#8217;s reputation in pharmaceutical mass production. Research into <a href=\"https:\/\/www.quantumrun.com\/prediction\/precision-healthcare-taps-your-genome-future-health-p3\" rel=\"nofollow\">precision medicine and genomics<\/a> would come decades later as the company expanded its R&#038;D capabilities.<\/p>\n\n<h2>Who is on the Board of Directors for Pfizer?<\/h2>\n\n<p>Pfizer&#8217;s board consists of 12 members who oversee corporate strategy, governance, and executive accountability. The board includes leaders from healthcare, technology, finance, and media sectors.<\/p>\n\n<h3>Healthcare and Scientific Expertise<\/h3>\n\n<p>Albert Bourla, DVM, Ph.D., holds the dual role of Chairman and CEO, having led the company since January 2019. He guided Pfizer through the COVID-19 pandemic response, overseeing development of the Comirnaty vaccine.<\/p>\n\n<p>Susan Desmond-Hellmann, M.D., M.P.H., brings decades of biotech experience, having previously served as CEO of the Bill &#038; Melinda Gates Foundation. Dan R. Littman, M.D., Ph.D., a professor at NYU Grossman School of Medicine, provides scientific research perspective. Scott Gottlieb, M.D., former FDA Commissioner, offers regulatory and public health insights relevant to <a href=\"https:\/\/www.quantumrun.com\/insight\/pharmacovigilance-automating-drug-surveillance\" rel=\"nofollow\">drug safety and surveillance<\/a>.<\/p>\n\n<h3>Technology and Business Leadership<\/h3>\n\n<p>Shantanu Narayen serves as Lead Independent Director while also holding the position of CEO at Adobe Inc. His technology background strengthens oversight of Pfizer&#8217;s digital and data initiatives.<\/p>\n\n<p>James Quincey, CEO of The Coca-Cola Company, and James C. Smith, former President of Thomson Reuters, provide global business and media expertise. Susan Hockfield, Ph.D., MIT&#8217;s first female president, adds academic and biotechnology governance experience.<\/p>\n\n<h3>Finance and Governance Directors<\/h3>\n\n<p>Mortimer J. Buckley, former CEO of Vanguard Group, joined the board in 2024 and brings investment management expertise. Ronald E. Blaylock, founder of GenNx360 Capital Partners, contributes private equity knowledge. Joseph J. Echevarria, former CEO of Deloitte, offers accounting and audit oversight experience. Suzanne Nora Johnson, former Vice Chairman of Goldman Sachs, rounds out the financial expertise on the board. Together, these directors guide decisions on capital allocation, risk management, and <a href=\"https:\/\/www.quantumrun.com\/Prediction\/experiencing-tomorrow%E2%80%99s-healthcare-system-future-health-p6\" rel=\"nofollow\">long-term healthcare strategy<\/a>.<\/p>\n\n<h2>Largest Shareholders of Pfizer<\/h2>\n\n<p>Pfizer&#8217;s top shareholders are predominantly passive index fund managers who hold shares on behalf of millions of individual retirement and investment accounts.<\/p>\n\n<div class=\"shareholder-table\">\n    <table>\n        <thead>\n            <tr>\n                <th>Shareholder<\/th>\n                <th>Ownership %<\/th>\n                <th>Approx. Shares<\/th>\n            <\/tr>\n        <\/thead>\n        <tbody>\n            <tr>\n                <td>Vanguard Group<\/td>\n                <td>9.2%<\/td>\n                <td>523M<\/td>\n            <\/tr>\n            <tr>\n                <td>BlackRock<\/td>\n                <td>6.3%<\/td>\n                <td>357M<\/td>\n            <\/tr>\n            <tr>\n                <td>State Street<\/td>\n                <td>5.3%<\/td>\n                <td>299M<\/td>\n            <\/tr>\n            <tr>\n                <td>Geode Capital<\/td>\n                <td>2.3%<\/td>\n                <td>129M<\/td>\n            <\/tr>\n            <tr>\n                <td>Wellington Management<\/td>\n                <td>1.8%<\/td>\n                <td>103M<\/td>\n            <\/tr>\n        <\/tbody>\n    <\/table>\n    <p class=\"source-note\">Source: <a href=\"https:\/\/www.marketscreener.com\/quote\/stock\/PFIZER-INC-23365019\/company\/\" rel=\"nofollow\" class=\"external\">MarketScreener<\/a>, August 2025<\/p>\n<\/div>\n\n<h3>The Big Three Asset Managers<\/h3>\n\n<p>Vanguard Group holds the largest stake at approximately 9.2%, representing over 523 million shares.<sup><a href=\"https:\/\/www.marketscreener.com\/quote\/stock\/PFIZER-INC-23365019\/company\/\" rel=\"nofollow\" class=\"external\">1<\/a><\/sup> Vanguard manages these shares primarily through index funds and ETFs on behalf of retirement savers. BlackRock, the world&#8217;s largest asset manager, controls about 6.3% of Pfizer through its iShares ETF products and actively managed funds. State Street Corporation rounds out the Big Three with approximately 5.3% ownership, mostly via SPDR ETFs.<\/p>\n\n<p>These three firms collectively control about 21% of Pfizer shares. While classified as passive investors, their combined voting power gives them substantial influence during annual shareholder meetings. They typically engage with management on governance, executive pay, and environmental policies.<\/p>\n\n<h3>Other Major Institutional Holders<\/h3>\n\n<p>Geode Capital Management holds 2.3% of shares, operating as a sub-advisor for many Vanguard funds. Wellington Management, an active investor with 1.8% ownership, takes a more hands-on approach to engagement with company leadership. Norges Bank Investment Management, Norway&#8217;s sovereign wealth fund, owns about 1.5% and prioritizes long-term sustainability in its investment decisions. UBS Asset Management, Northern Trust, and State Farm Insurance each hold approximately 1% of Pfizer stock. According to industry forecasts, <a href=\"https:\/\/www.quantumrun.com\/future-timeline\/2026\/future-timeline-subpost-health\" rel=\"nofollow\">healthcare sector growth<\/a> may continue attracting institutional investment.<\/p>\n\n<h3>Activist Investor Pressure<\/h3>\n\n<p>In 2024, activist hedge fund Starboard Value acquired roughly $1 billion in Pfizer shares. Though representing less than 1% ownership, Starboard has pushed for cost reductions and improved shareholder returns. CEO Albert Bourla responded by announcing $500 million in additional operating expense savings for 2025, on top of a prior $4 billion cost-cutting initiative.<\/p>\n\n<div class=\"faq-section\">\n<h2>FAQs<\/h2>\n\n<h3>Who founded Pfizer?<\/h3>\n<p>Charles Pfizer and Charles Erhart, German immigrant cousins, founded the company in Brooklyn, New York, in 1849. They started by producing santonin, an antiparasitic drug.<\/p>\n\n<h3>Is Pfizer owned by the U.S. government?<\/h3>\n<p>No. Pfizer is a publicly traded company owned by private investors and institutions. The U.S. government has contracted with Pfizer but holds no ownership stake.<\/p>\n\n<h3>Who is Pfizer&#8217;s largest shareholder?<\/h3>\n<p>Vanguard Group is the largest shareholder with approximately 9.2% of outstanding shares, held through index funds and ETFs on behalf of individual investors.<\/p>\n\n<h3>Is Pfizer connected to Johnson &#038; Johnson?<\/h3>\n<p>No. Pfizer and Johnson &#038; Johnson are separate, competing pharmaceutical companies with independent ownership structures and no shared equity holdings.<\/p>\n\n<h3>What country is Pfizer based in?<\/h3>\n<p>Pfizer is an American company headquartered in New York City. It was founded in the United States in 1849 and remains incorporated under U.S. law.<\/p>\n<\/div>\n\n<\/body>\n<\/html>\n","protected":false},"excerpt":{"rendered":"<p>Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide: ~81,000 Pfizer Inc. is not owned by any single individual or entity. As a publicly traded company listed on the New York Stock Exchange under the ticker symbol PFE, ownership is distributed among institutional investors, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17957,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[244],"tags":[],"class_list":["post-17956","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-who-owns"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Who Owns Pfizer<\/title>\n<meta name=\"description\" content=\"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Who Owns Pfizer\" \/>\n<meta property=\"og:description\" content=\"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/\" \/>\n<meta property=\"og:site_name\" content=\"Quantumrun Foresight\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-03T09:42:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-03T09:44:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1182\" \/>\n\t<meta property=\"og:image:height\" content=\"790\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Richard Jaimes\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Richard Jaimes\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/\"},\"author\":{\"name\":\"Richard Jaimes\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/person\\\/5a0afcb410d8e3137f58d5a201809011\"},\"headline\":\"Who Owns Pfizer\",\"datePublished\":\"2026-02-03T09:42:14+00:00\",\"dateModified\":\"2026-02-03T09:44:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/\"},\"wordCount\":1121,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/who-owns-pfizer-e1770111720594.png\",\"articleSection\":[\"Who Owns\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/\",\"name\":\"Who Owns Pfizer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/who-owns-pfizer-e1770111720594.png\",\"datePublished\":\"2026-02-03T09:42:14+00:00\",\"dateModified\":\"2026-02-03T09:44:11+00:00\",\"description\":\"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/who-owns-pfizer-e1770111720594.png\",\"contentUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/who-owns-pfizer-e1770111720594.png\",\"width\":1182,\"height\":790,\"caption\":\"Pfizer ownership breakdown with $142B market cap, top institutional shareholders table, board composition, and 1849 founding history.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns-pfizer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Who Owns\",\"item\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/who-owns\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Who Owns Pfizer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#website\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\",\"name\":\"Quantumrun Foresight\",\"description\":\"Thrive from future trends.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#organization\",\"name\":\"Quantumrun Foresight\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/cropped-con-logo-00.png\",\"contentUrl\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/cropped-con-logo-00.png\",\"width\":286,\"height\":55,\"caption\":\"Quantumrun Foresight\"},\"image\":{\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/#\\\/schema\\\/person\\\/5a0afcb410d8e3137f58d5a201809011\",\"name\":\"Richard Jaimes\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g\",\"caption\":\"Richard Jaimes\"},\"sameAs\":[\"https:\\\/\\\/www.quantumrun.com\\\/consulting\"],\"url\":\"https:\\\/\\\/www.quantumrun.com\\\/consulting\\\/author\\\/admin-stcons\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Who Owns Pfizer","description":"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/","og_locale":"en_US","og_type":"article","og_title":"Who Owns Pfizer","og_description":"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:","og_url":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/","og_site_name":"Quantumrun Foresight","article_published_time":"2026-02-03T09:42:14+00:00","article_modified_time":"2026-02-03T09:44:11+00:00","og_image":[{"width":1182,"height":790,"url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png","type":"image\/png"}],"author":"Richard Jaimes","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Richard Jaimes","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#article","isPartOf":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/"},"author":{"name":"Richard Jaimes","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/person\/5a0afcb410d8e3137f58d5a201809011"},"headline":"Who Owns Pfizer","datePublished":"2026-02-03T09:42:14+00:00","dateModified":"2026-02-03T09:44:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/"},"wordCount":1121,"commentCount":0,"publisher":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#organization"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png","articleSection":["Who Owns"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/","url":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/","name":"Who Owns Pfizer","isPartOf":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#primaryimage"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png","datePublished":"2026-02-03T09:42:14+00:00","dateModified":"2026-02-03T09:44:11+00:00","description":"Key Stats Market Cap: ~$142 billion (August 2025) Projected 2025 Revenue: $61\u201364 billion Institutional Ownership: ~68% of shares Employees Worldwide:","breadcrumb":{"@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#primaryimage","url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png","contentUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2026\/02\/who-owns-pfizer-e1770111720594.png","width":1182,"height":790,"caption":"Pfizer ownership breakdown with $142B market cap, top institutional shareholders table, board composition, and 1849 founding history."},{"@type":"BreadcrumbList","@id":"https:\/\/www.quantumrun.com\/consulting\/who-owns-pfizer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.quantumrun.com\/consulting\/"},{"@type":"ListItem","position":2,"name":"Who Owns","item":"https:\/\/www.quantumrun.com\/consulting\/who-owns\/"},{"@type":"ListItem","position":3,"name":"Who Owns Pfizer"}]},{"@type":"WebSite","@id":"https:\/\/www.quantumrun.com\/consulting\/#website","url":"https:\/\/www.quantumrun.com\/consulting\/","name":"Quantumrun Foresight","description":"Thrive from future trends.","publisher":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.quantumrun.com\/consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.quantumrun.com\/consulting\/#organization","name":"Quantumrun Foresight","url":"https:\/\/www.quantumrun.com\/consulting\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/logo\/image\/","url":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2020\/07\/cropped-con-logo-00.png","contentUrl":"https:\/\/www.quantumrun.com\/consulting\/wp-content\/uploads\/2020\/07\/cropped-con-logo-00.png","width":286,"height":55,"caption":"Quantumrun Foresight"},"image":{"@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.quantumrun.com\/consulting\/#\/schema\/person\/5a0afcb410d8e3137f58d5a201809011","name":"Richard Jaimes","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/552ad8a69a374ceb309e1045d345be2d8c30e8a0e8cda42acb1fc357ca381509?s=96&d=mm&r=g","caption":"Richard Jaimes"},"sameAs":["https:\/\/www.quantumrun.com\/consulting"],"url":"https:\/\/www.quantumrun.com\/consulting\/author\/admin-stcons\/"}]}},"_links":{"self":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/17956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/comments?post=17956"}],"version-history":[{"count":2,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/17956\/revisions"}],"predecessor-version":[{"id":17959,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/posts\/17956\/revisions\/17959"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/media\/17957"}],"wp:attachment":[{"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/media?parent=17956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/categories?post=17956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.quantumrun.com\/consulting\/wp-json\/wp\/v2\/tags?post=17956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}